Skip to main content
Log in

Trikuspidalklappenersatz bei erworbenem, isolierten Trikuspidalklappenvitium

Früh– und mittelfristige Ergebnisse

Tricuspid valve replacement for acquired isolated tricuspid valve disease – operative and mid–term results

  • ORIGINALARBEIT
  • Published:
Zeitschrift für Herz-,Thorax- und Gefäßchirurgie Aims and scope

Zusammenfassung

Ein erworbenes isoliertes Trikuspidalklappenvitium ist eine seltene Herzklappenerkrankung. Wir möchten in dieser Arbeit die präoperativen Charakteristika sowie den Langzeitverlauf der Patienten darstellen, die sich in unserer Klinik einem isolierten Trikuspidalklappenersatz bei erworbenem Trikuspidalklappenvitium unterzogen haben.

Wir identifizierten 126 Patienten, die in unserer Klinik in einem Zeitraum vom 01. 01. 1985 bis 31. 07. 2003 einen Trikuspidalklappenersatz erhielten. 28 dieser Patienten (16 weiblich, mittleres Alter 53,6 Jahre) unterzogen sich 30 isolierten Trikuspidalklappenersätzen bei erworbener Trikuspidalklappeninsuffizienz.

Die mittlere Nachbeobachtungszeit betrug 38 (1–221) Monate. Bei 3 Patienten war die Ursache für die Trikuspidalklappeninsuffizienz eine floride Endokarditis, bei 6 Patienten eine chronische Endokarditis. 1 Patient litt unter einer chronischen Perimyokarditis, 2 unter einer hypertrophen, nicht–obstruktiven Kardiomyopathie und 1 unter einer Endomyokardfibrose. 4 Patienten waren herztransplantiert und bei einem Patienten lag ein Zustand nach zweimaliger Perikardresektion bei Perikarditis constrictiva vor. 3 Patienten waren auswärts voroperiert (2 Trikuspidalklappenersätze und 1 Trikuspidalklappenresektion).

Es wurden 10 biologische und 20 Alloprothesen implantiert. 1 Patient starb perioperativ (3,6%), 6 im Nachbeobachtungszeitraum (21%). 2 Patienten mussten sich einem Klappenaustausch unterziehen: eine Patientin nach Prothesenendokarditis einer biologischen Prothese, eine weitere Patientin nach Thrombosierung einer Alloprothese. Degeneration der biologischen Prothesen oder antikoagulantien–induzierte Blutungen wurden im Verlauf nicht beobachtet. 18 der überlebenden Patienten waren zum Zeitpunkt der Evaluation in NYHA–Klasse I, 2 Patienten in Klasse II und 1 Patient in Klasse II–III.

Ein isolierter Trikuspidalklappenersatz kann mit den derzeit verfügbaren Herzklappenprothesen sicher durchgeführt werden. Die mittelfristigen Ergebnisse sind akzeptabel und abhängig von Kormorbiditäten und der zugrunde liegenden Herzerkrankung.

Summary

Isolated tricuspid valve replacement for acquired tricuspid valve disease is rare. We studied the etiologies leading to tricuspid valve replacement, the preoperative conditions and the postoperative outcome of patients who underwent isolated tricuspid valve replacement at our institution.

From the clinical database we identified all patients (n = 126) who underwent tricuspid valve replacement between 01 January 1985 and 31 July 2003. We encountered 28 consecutive patients (16 female, mean age 53.6 years) who underwent 30 isolated tricuspid valve replacements for acquired tricuspid valve insufficiency.

The mean follow–up time for these patients averaged 38 (1–221) months. Tricuspid valve regurgitation was caused in 3 patients by infective, in 6 patients by healed endocarditis, 1 patient suffered from healed perimyocarditis, 2 from hypertrophic non–obstructive cardiomyopathy and 1 from endomyocardial fibrosis. In one patient the tricuspid insufficiency was related to constrictive pericarditis and in 4 patients to prior heart transplantation. Two patients underwent previous tricuspid valve replacement and one tricuspid valve resection in other institutions. Twenty patients received mechanical valves, 10 bioprostheses. One patient died perioperatively (3.6%), 6 during the follow–up time (21%). Two patients underwent a redo–operation, one due to prosthetic endocarditis of a biological prosthesis, the other after thrombosis of a mechanical prosthesis. No structural deterioration of biological prostheses, no bleeding due to anticoagulation with mechanical prostheses occurred. Of the surviving patients 18 were in New York Heart Association functional class I, two in class II and one in II–III at the time of the follow–up.

Isolated tricuspid valve replacement for acquired tricuspid valve insufficiency is rarely performed and due to a multitude of different etiologies. Perioperative mortality and morbidity and prosthesis related complications are comparatively lower than previously reported. The mid–term results are largely dependent on the etiology of the regurgitation and the patients’ comorbidity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Aziz TM, Saad RA, Burgess MI, Campbell CS, Yonan NA (2002) Clinical significance of tricuspid valve dysfunction after orthotopic heart transplantation. J Heart Lung Transplant 21:1101–1108

    Article  PubMed  Google Scholar 

  2. Carpentier A, Deloche A, Hanania G, Forman J, Sellier P, Piwnica A, Dubost C, McGoon DC (1974) Surgical management of acquired tricuspid valve disease. J Thorac Cardiovasc Surg 67:53–65

    PubMed  Google Scholar 

  3. Carrier M, Hebert Y, Pellerin M, Bouchard D, Perrault LP, Cartier R, Basmajian A, Page P, Poirier NC (2003) Tricuspid valve replacement: an analysis of 25 years of experience at a single center. Ann Thorac Surg 75:47–50

    Article  PubMed  Google Scholar 

  4. Castedo E, Canas A, Cabo RA, Burgos R, Ugarte J (2003) Edge–to–Edge tricuspid repair for redeveloped valve incompetence after DeVega’s annuloplasty. Ann Thorac Surg 75:605–606

    Article  PubMed  Google Scholar 

  5. De Bonis M, Lapenna E, La Canna G, Grimaldi A, Maisano F, Torracca L, Caldarola A, Alfieri O (2004) A novel technique for correction of severe tricuspid valve regurgitation due to complex lesions. Eur J Cardiothorac Surg 25:760–765

    PubMed  Google Scholar 

  6. De Vega NG (1972) [Selective, adjustable and permanent annuloplasty. An original technic for the treatment of tricuspid insufficiency]. Rev Esp Cardiol 25:555–556

    PubMed  Google Scholar 

  7. Hansky B, Güldner H, Vogt J, Minami K, Tenderich G, Horstkotte D, Körfer R (2002) Coronary vein leads for cardiac pacing in patients with tricuspid valve replacement. Thorac Cardiovasc Surg 50:120–121

    PubMed  Google Scholar 

  8. Jeevanandam V, Russell H, Mather P, Furukawa S, Anderson A, Grzywacz F, Raman J (2004) A one–year comparison of prophylactic donor tricuspid annuloplasty in heart transplantation. Ann Thorac Surg 78:759–766

    Article  PubMed  Google Scholar 

  9. Kaplan M, Kut MS, Demirtas MM, Cimen S, Ozler A (2002) Prosthetic replacement of tricuspid valve: bioprosthetic or mechanical. Ann Thorac Surg 73:467–473

    PubMed  Google Scholar 

  10. Kawano H, Oda T, Fukunaga S, Tayama E, Kawara T, Oryoji A, Aoyagi S (2000) Tricuspid valve replacement with the St. Jude Medical valve: 19 years of experience. Eur J Cardiothorac Surg 18:565–569

    PubMed  Google Scholar 

  11. Maleszka A, Kleikamp G, Körfer R (2004) Tricuspid valve replacement: clinical long–term results for acquired isolated tricuspid valve regurgitation. J Heart Valve Dis 13:957–961

    PubMed  Google Scholar 

  12. Mangoni AA, DiSalvo TG, Vlahakes GJ, Polanczyk CA, Fifer MA (2001) Outcome following isolated tricuspid valve replacement. Eur J Cardiothorac Surg 19:68–73

    PubMed  Google Scholar 

  13. Mantri RR, Radhakrishnan S, Sinha N, Goel PK, Bajaj R, Bidwai PS (1993) Atrio–ventricular regurgitations in constrictive pericarditis: incidence and post–operative outcome. Int J Cardiol 38:273–279

    Article  PubMed  Google Scholar 

  14. Miro JM, Moreno A, Mestres CA (2003) Infective Endocarditis in Intravenous Drug Abusers. Curr Infect Dis Rep 5:307–316

    PubMed  Google Scholar 

  15. Nakano K, Ishibashi–Ueda H, Kobayashi J, Sasako Y, Yagihara T (2001) Tricuspid valve replacement with bioprostheses: long–term results and causes of valve dysfunction. Ann Thorac Surg 71:105–109

    PubMed  Google Scholar 

  16. Ratnatunga CP, Edwards MB, Dore CJ, Taylor KM (1998) Tricuspid valve replacement: UK Heart Valve Registry mid–term results comparing mechanical and biological prostheses. Ann Thorac Surg 66:1940–1947

    PubMed  Google Scholar 

  17. Solomon NA, Lim RC, Nand P, Graham KJ (2004) Tricuspid valve replacement: bioprosthetic or mechanical valve? Asian Cardiovasc Thorac Ann 12:143–148

    PubMed  Google Scholar 

  18. Thorburn CW, Morgan JJ, Shanahan MX, Chang VP (1983) Long–term results of tricuspid valve replacement and the problem of prosthetic valve thrombosis. Am J Cardiol 51:1128–1132

    Article  PubMed  Google Scholar 

  19. Van Nooten GJ, Caes F, Taeymans Y, Van Belleghem Y, Francois K, De Bacquer D, Deuvaert FE, Wellens F, Primo G (1995) Tricuspid valve replacement: postoperative and long–term results. J Thorac Cardiovasc Surg 110:672–679

    PubMed  Google Scholar 

  20. Yankah AC, Musci M, Weng Y, Loebe M, Zurbruegg HR, Siniawski H, Mueller J, Hetzer R (2000) Tricuspid valve dysfunction and surgery after orthotopic cardiac transplantation. Eur J Cardiothorac Surg 17:343–348

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ariane Maleszka.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maleszka, A., Hansky, B., Körfer, R. et al. Trikuspidalklappenersatz bei erworbenem, isolierten Trikuspidalklappenvitium. Z Herz- Thorax- Gefäßchir 19, 162–166 (2005). https://doi.org/10.1007/s00398-005-0501-5

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00398-005-0501-5

Schlüsselwörter

Key words

Navigation